The Global Epigenetics Diagnostic market is estimated to reach $22.5 billion by 2026, with a projected CAGR of 16.2% during the forecast period.
TABLE OF CONTENTS Chapter 1 Introduction 1.1 Executive Summary 1.2 Market Definition 1.3 Market Scope Chapter 2 Research Methodology 2.1 Primary Research 2.2 Research Methodology 2.3 Assumptions & Exclusions 2.4 Secondary Data Sources Chapter 3 Market Overview 3.1 Report Segmentation & Scope 3.2 Key Market Trends 3.2.1 Drivers 3.2.2 Restraints 3.2.3 Opportunities 3.3 Porter’s Five Forces Analysis 3.4 Market Share Analysis Chapter 4 Global Epigenetics Diagnostic Market by Product: Market Size and Forecast, 2018 – 2026 4.1 Introduction 4.1.1 Market Size and Forecast 4.2 Reagents 4.2.1 Market Size and Forecast 4.3 Kits 4.3.1 Market Size and Forecast 4.3.2 Chip Sequencing Kit 4.3.2.1 Market Size and Forecast 4.3.3 Whole Genomic Amplification Kit 4.3.3.1 Market Size and Forecast 4.3.4 Bisulfite Conversion Kit 4.3.4.1 Market Size and Forecast 4.3.5 RNA Sequencing Kit 4.3.5.1 Market Size and Forecast 4.3.6 Others 4.3.6.1 Market Size and Forecast 4.4 Instruments 4.4.1 Market Size and Forecast 4.5 Enzymes 4.5.1 Market Size and Forecast 4.6 Services 4.6.1 Market Size and Forecast Chapter 5 Global Epigenetics Diagnostic Market by Technology: Market Size and Forecast, 2018 – 2026 5.1 Introduction 5.1.1 Market Size and Forecast 5.2 DNA Methylation 5.2.1 Market Size and Forecast 5.3 Histone Methylation 5.3.1 Market Size and Forecast 5.4 Histone Acetylation 5.4.1 Market Size and Forecast 5.5 MicoRNA Modification 5.5.1 Market Size and Forecast 5.6 Large Non-Coding RNA 5.6.1 Market Size and Forecast 5.7 Chromatin Structure 5.7.1 Market Size and Forecast Chapter 6 Global Epigenetics Diagnostic Market by Application: Market Size and Forecast, 2018 – 2026 6.1 Introduction 6.1.1 Market Size and Forecast 6.2 Oncology 6.2.1 Market Size and Forecast 6.2.2 Solid Tumors 6.2.2.1 Market Size and Forecast 6.2.3 Liquid Tumors 6.2.3.1 Market Size and Forecast 6.3 Non-Oncology 6.3.1 Market Size and Forecast 6.3.2 Metabolic Diseases 6.3.2.1 Market Size and Forecast 6.3.3 Inflammatory Diseases 6.3.3.1 Market Size and Forecast 6.3.4 Cardiovascular Diseases 6.3.4.1 Market Size and Forecast 6.3.5 Infectious Diseases 6.3.5.1 Market Size and Forecast 6.3.6 Others 6.3.6.1 Market Size and Forecast Chapter 7 Global Epigenetics Diagnostic Market by Geography: Market Size and Forecast, 2018 – 2026 7.1 Introduction 7.1.1 Market Size and Forecast 7.2 North America 7.2.1 North America Market Size & Forecast, By Country 7.2.2 North America Market Size & Forecast, By Product 7.2.3 North America Market Size & Forecast, By Technology 7.2.4 North America Market Size & Forecast, By Application 7.2.5 The U.S. 7.2.5.1 Market Size and Forecast 7.2.6 Canada 7.2.6.1 Market Size and Forecast 7.2.7 Mexico 7.2.7.1 Market Size and Forecast 7.3 Europe 7.3.1 Europe Market Size and Forecast, By Country 7.3.2 Europe Market Size and Forecast, By Product 7.3.3 Europe Market Size and Forecast, By Technology 7.3.4 Europe Market Size and Forecast, By Application 7.3.5 UK 7.3.5.1 Market Size and Forecast 7.3.6 Germany 7.3.6.1 Market Size and Forecast 7.3.7 France 7.3.7.1 Market Size and Forecast 7.3.8 Italy 7.3.8.1 Market Size and Forecast 7.3.9 Spain 7.3.9.1 Market Size and Forecast 7.3.10 Rest of Europe 7.3.10.1 Market Size and Forecast 7.4 Asia-Pacific 7.4.1 Asia-Pacific Market Size and Forecast, By Country 7.4.2 Asia-Pacific Market Size and Forecast, By Product 7.4.3 Asia-Pacific Market Size and Forecast, By Technology 7.4.4 Asia-Pacific Market Size and Forecast, By Application 7.4.5 India 7.4.5.1 Market Size and Forecast 7.4.6 China 7.4.6.1 Market Size and Forecast 7.4.7 Australia 7.4.7.1 Market Size and Forecast 7.4.8 Japan 7.4.8.1 Market Size and Forecast 7.4.9 South Korea 7.4.9.1 Market Size and Forecast 7.4.10 Rest of Asia-Pacific 7.4.10.1 Market Size and Forecast 7.5 South America 7.5.1 South America Market Size and Forecast, By Country 7.5.2 South America Market Size and Forecast, By Product 7.5.3 South America Market Size and Forecast, By Technology 7.5.4 South America Market Size and Forecast, By Application 7.5.5 Brazil 7.5.5.1 Market Size and Forecast 7.5.6 Rest of South America 7.5.6.1 Market Size and Forecast 7.6 RoW 7.6.1 RoW Market Size and Forecast, By Country 7.6.2 RoW Market Size and Forecast, By Product 7.6.3 RoW Market Size and Forecast, By Technology 7.6.4 RoW Market Size and Forecast, By Application 7.6.5 Middle East 7.6.5.1 Market Size and Forecast 7.6.6 Africa 7.6.6.1 Market Size and Forecast Chapter 8 Company Profiles 8.1 Diagenode Diagnostics 8.2 Eisai Co. Ltd. 8.3 EpiGen 8.4 Illumina, Inc. 8.5 Novartis AG 8.6 Oncolys Biopharma Inc. 8.7 Qiagen 8.8 Roche Diagnostics 8.9 Sigma-Aldrich Corporation 8.10 Thermo Fisher Scientific, Inc. 8.11 Valirx Plc 8.12 Zymo Research Corporation
(US)
